A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...